Home Featured Page 121

Featured

Latest

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

PT388 – Vital Psychedelic Conversations

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent...

Bullseye Chart: The Psychedelic Drug Development Pipeline

Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics...

Opinions | Australia’s Rescheduling of MDMA and Psilocybin a Welcome First...

Panel: Neuroimaging in Psychedelic Research

PT387 – Psychedelic Ethics & Self-Reflexivity and Proposition 122 Conflict &...

Optimi Health Submits Phase I Clinical Trial Application Combining The Use...

PharmaTher Submits FDA Meeting Package to Discuss 505(b)(2) Pathway for New...

Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal...

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

test

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

PT388 – Vital Psychedelic Conversations

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent...

Bullseye Chart: The Psychedelic Drug Development Pipeline

Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics...

Opinions | Australia’s Rescheduling of MDMA and Psilocybin a Welcome First...

Panel: Neuroimaging in Psychedelic Research

PT387 – Psychedelic Ethics & Self-Reflexivity and Proposition 122 Conflict &...

Optimi Health Submits Phase I Clinical Trial Application Combining The Use...

PharmaTher Submits FDA Meeting Package to Discuss 505(b)(2) Pathway for New...

Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal...

EDITOR PICKS

test

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY